The non-invasive cancer diagnostics market is projected to grow at annualized rate of nearly 20%, between 2019 and 2030, claims Roots Analysis

Market-Research

Given the invasive and cost-intensive nature of tissue biopsies, there is a significant unmet need for safer and more patient-friendly cancer diagnostics that are capable of offering highly accurate, and actionable insights related to the disease

Submitted by Roots_Analysis on 2020-04-22 12:48.

The cell and advanced therapies supply chain management market is anticipated to grow at an annualized rate of 11% till 2030, claims Roots Analysis

Market-Research

Over time, biopharmaceutical companies have realized the importance of integrating advanced software into the cell and advanced therapies supply chain. Such upgrades have demonstrated the ability to offer both time and cost saving

Submitted by Roots_Analysis on 2020-04-22 12:35.

Human Microbiome-based Products Market is projected to be worth over USD 4 Billion by 2030, growing at an annualized rate of over 40%, claims Roots Analysis

Market-Research

Over the years, extensive R&D efforts have established the basis for a wide range of microbiome-based therapeutic and diagnostic products, which may cause a paradigm shift in the way healthcare is delivered in the foreseen future

Submitted by Roots_Analysis on 2020-04-21 14:49.

Growing at an annualized rate of over 20%, the cell therapy manufacturing market is estimated to reach close to USD 10 Billion by 2030, claims Roots Analysis

Market-Research

The approval of KYMRIAH®, YESCARTA®, Alofisel® and Zyntelgo® has increased the interest of pharma stakeholders in cell therapies; further, owing to the technical challenges in this field, outsourcing manufacturing operations has become a necessity

Submitted by Roots_Analysis on 2020-04-21 14:43.

The prefilled syringes market is estimated to be worth over USD 2.5 billion by 2030, claims Roots Analysis

Market-Research

Prefilled syringes present an attractive packaging option that doubles as an easy-to-use drug delivery device, and a product life cycle management tool. Consequently, they have become indispensable within the modern healthcare industry

Submitted by Roots_Analysis on 2020-04-21 14:37.

The autoinjectors market is projected to be worth around USD 1.5 Billion by 2030, claims Roots Analysis

Market-Research

Rise in prevalence of chronic diseases and the corresponding need to medicate frequently, have led to an increase in demand for safe, self-administrable dosing options. Autoinjectors are considered among the leading product classes in this category

Submitted by Roots_Analysis on 2020-04-21 14:27.

The DNA-encoded libraries platforms and services market is projected to be reach USD 4 billion by 2030, growing at an annualized rate of 17%, claims Roots Analysis

Consulting

Using DNA to develop encoded libraries of pharmacological leads has enabled medical research community to assemble and maintain large collections of compounds in singular reaction tubes, capturing the attention of small and big pharma players

Submitted by Roots_Analysis on 2020-04-21 14:09.

The contract regulatory affairs-management services market for medical devices is estimated to be worth USD 820 million by 2030, growing at a CAGR of 6.9%, claims Roots Analysis

Market-Research

In order to reduce risk of device recalls and expedite time to market, medical device developers rely on contract service providers for regulatory submissions and navigating various challenging aspects of the product review and approval process

Submitted by Roots_Analysis on 2020-04-20 11:02.

Growing at an annualized rate of nearly 10%, the companion diagnostics services market is estimated to reach USD 800+ Million by 2030, claims Roots Analysis

Market-Research

Outsourcing is presently considered the preferred business model for the development of companion diagnostic tests for personalized therapeutic interventions

Roots Analysis has announced the addition of ... Read more

Submitted by Roots_Analysis on 2020-04-20 10:58.

With over 280 therapies under evaluation, the stem cell therapy market is estimated to be worth USD 8.5 Billion by 2030, claims Roots Analysis

Market-Research

The success of approved stem cell therapies has caused a surge in interest of biopharma developers in this field; many innovator companies are currently progressing proprietary leads across different phases of clinical development, with cautious optimism

Submitted by Roots_Analysis on 2020-04-20 10:54.

In silico drug discovery services market is likely to be worth USD 124 million by 2030, growing at an annualized rate of 15.6%, claims Roots Analysis

Market-Research

Roots Analysis has announced the addition of “In Silico / Computer-Aided Drug Discovery Services Market: Focus on Large Molecules ... Read more

Submitted by Roots_Analysis on 2020-04-20 10:49.

Growing at an annualized rate of over 10%, the prefilled syringe fill / finish services market is estimated to reach close to USD 3 Billion by 2030, claims Roots Analysis

Market-Research

Driven by the growing pipeline of injectable drugs, and increasing preference for self-medication, the demand for fill/finish services is anticipated to present lucrative opportunities for contract service providers in the biopharmaceutical industry

Submitted by Roots_Analysis on 2020-04-20 10:24.

The RNAi therapeutics market is anticipated to grow at an annualized rate of more than 45%, till 2030, claims Roots Analysis

Pharmaceuticals

The recent approval of first RNAi therapeutic, ONPATTROTM, has caused a surge in interest of the industry / non-industry players in upcoming field of pharmacological research

Roots Analysis has ... Read more

Submitted by Roots_Analysis on 2020-04-17 12:48.

The next generation immune checkpoint inhibitors and stimulators market is projected to be worth USD 12.5 billion, growing at a CAGR of 15%, claims Roots Analysis

Market-Research

The success of CTLA4, PD-1, and PD-L1 inhibitors paved the way for researchers to explore the vast therapeutic potential of immune checkpoint modulation, enabling the discovery of product candidates against clinical conditions beyond oncology

Submitted by Roots_Analysis on 2020-04-17 12:47.

Pages